Botanical species · safety record

Rhaponticum uniflorum

The EFSA Compendium of Botanicals holds 6 constituent measurements for Rhaponticum uniflorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rhaponticum uniflorum (L.) DC

6Constituent measurements

0Safety records

5Cited sources

14Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 14 licensed products naming Rhaponticum uniflorum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Diterpene lactones	Unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Glycyrrhizic acid	Unspecified	Solvent extraction	≤ 101.2 Microgram/millilitre	HPLC-DAD	No resolvable identifier
Glycyrrhizic acid	Unspecified	Solvent extraction	≥ 0.5 Microgram/millilitre	HPLC-DAD	No resolvable identifier
Lignans	Flower	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Pentacyclic triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Steroidal triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Liu, Bin., Shi, Renbing., Tu, Guangzhong., Wang, Wei., Yang, Chunmei. Isolation and identification of diosbulbin-B in the aqueous extraction of Rhaponticum uniflorum. Beijing zhongyiyao daxue xuebao, 2004, p. 58-60.
Zhang, YH., Lu, ZG., Li, XP., Wang, HQ. A new triterpenoid saponin from Rhaponticum unifloram (Compositae). ACTA BOTANICA SINICA, 2002, vol. 44, no. 3, p. 359-361.
Zhang, YH., Cheng, JK., Yang, L., Cheng, DL. Triterpenoids from Rhaponticum uniflorum. Journal of the chinese chemical society, 2002, vol. 49, no. 1, p. 117-124.
Zhou, Ting., Tan, Xiao-bin., Feng, Liang., Jia, Xiao-bin. Simultaneous determination of six ingredients contents in Rhaponticum uniflorum by HPLC. Zhongyaocai, 2015, p. 544-547.
Bao, Xiao-mei., Liu, Le-le., Luo, Su-qin., Yang, Qiao-he. Studies on chemical constituents of the flower of Rhaponticum uniflorum. Zhonghua zhongyiyao zazhi, 2012, p. 1914-1915.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature